Institute of
bioorganic chemistry

Lectin-modified nano-PLGA nanoparticles loaded with photodynamic therapy sensitizer (IR775) and magnetite (mPLGA/IR775) were shown to be effective theranostic agents, realizing effective magnetically assisted targeted delivery, tumor bioimaging, and treatment under external light irradiation. The in vitro and in vivo functionality of these nanoparticles were thoroughly tested, and 100% inhibition of allograft solid tumor growth was shown, thus confirming the great potential of the developed nanoformulation for bioimaging and photodynamic therapy. The results are published in Pharmaceutics. Learn more

Plants utilize small secreted peptides as important mediators of many processes, including growth and response to stress conditions. One of such regulators is the conservative 5 kDa cysteine-rich RALF (Rapid Alkalinization Factor) peptide family, which is widely present in terrestrial plants. A group of scientists from the Laboratory for Systemic Analysis of Proteins and Peptides of IBCh RAS, together with colleagues from Moscow State University, Peoples' Friendship University of Russia, Center of Physical-Chemical Medicine, and Moscow Institute of Physics and Technology, showed that RALFs regulate the immune response in the moss Physcomitrium patens. This study extends our knowledge of the adaptive significance and conserved functions of RALF peptides in terrestrial plants. The work was published in Frontiers in Plant Science (IF=6.6). Learn more

The scientists from the Department of Adaptive Immunity Genomics of the IBCH RAS together with colleagues from the Rogachev NMRC DGOI developed the first fully computational method to correct quantitative bias in the T and B-cell receptor gene repertoires (TCR and BCR) obtained using multiplex PCR. These quantitative biases are associated with heterogeneous primer efficiencies and the exponential nature of PCR. This study identified multiplex PCR-specific anomalies in the frequencies of segments within the nonfunctional TCR and BCR rearrangements. OAR coefficients were proposed to quantify such anomalies, based on which an algorithm for quantitative bias correction was created. The efficiency of the algorithm was confirmed by several independent experiments. The results are published in the eLife.

Employing antibody fragments instead of full-length antibodies in antibody-drug conjugates can facilitate accumulation of the therapeutics in the tumor and reduce their side effects. Scientists from the Laboratory of molecular immunology together with colleagues from the Laboratory of cell interactions, the Laboratory of molecular diagnostics at IBCh RAS, and other Russian Institutes have for the first time developed GD2-specific antibody fragment-drug conjugates. Minibody and scFv fragment conjugates with the tubulin-inhibiting drugs MMAE and MMAF manifested strong cytotoxic and cytostatic effects in GD2-positive neuroblastoma and melanoma cell lines. The work is published in the International Journal of Molecular Sciences. Learn more

A group of scientists from the Laboratory of Molecular Design and Synthesis, the Protein Growth and Differentiation Factor Expression Group of the Institute of Bioorganic Chemistry, Russian Academy of Sciences, the Institute of Poliomyelitis and other institutes synthesized a series of compounds based on 5-(perylene-3-ylethynyl)uracil and studied their antiviral properties and mechanism of action. Previous studies of this class of compounds have suggested controversial types of mechanisms of action. Nonetheless providing comparable high activity. The present study showed that, upon irradiation with light, amphiphilic compounds accumulated in cell and viral membranes inhibit the entry of enveloped viruses into the cell. The results are published in the Antiviral Research. Learn more